Vault-13

Venrock Adviser, LLC

NEW YORK, NY · CIK 1615982 · 13F filing filed 2023-11-14

SEC-registered investment adviser since 2014 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 11
Palo Alto, CAUnited States United States

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$949.9m reported value +51.9% vs Q2 2023
37positions
62.2%in top 10
10 new 7 added 3 reduced 3 sold out vs Q2 2023

Holdings, Q3 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 APOGEE THERAPEUTICS INC COM COM 8,493,321 $180.9m19.04% 19.04% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 8.5m
2 RAYZEBIO INC COM COM 4,016,847 $89.2m9.39% 9.39% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 4.0m
3 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 3,082,622 $47.3m4.98% 4.98% UnchangedShares held: Q4 2022 2.7m, Q1 2023 2.7m, Q2 2023 3.1m, Q3 2023 3.1m
4 COGENT BIOSCIENCES INC COM COGT COGT 4,684,167 $45.7m4.81% 4.81% AddedShares held: Q4 2022 4.0m, Q1 2023 4.9m, Q2 2023 4.7m, Q3 2023 4.7m +35 +35 0.0%
5 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 14,444,444 $45.6m4.80% 4.80% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 14.4m
6 MERUS N V COM MRUS MRUS 1,726,214 $40.7m4.28% 4.28% UnchangedShares held: Q4 2022 1.2m, Q1 2023 1.2m, Q2 2023 1.7m, Q3 2023 1.7m
7 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 2,954,902 $40.4m4.25% 4.25% AddedShares held: Q4 2022 0, Q1 2023 2.2m, Q2 2023 2.2m, Q3 2023 3.0m +724.8k +724,775 32.5%
8 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 3,000,000 $38.2m4.02% 4.02% UnchangedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 3.0m, Q3 2023 3.0m
9 PHARVARIS N V COM PHVS PHVS 1,563,513 $32.6m3.43% 3.43% AddedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 1.3m, Q3 2023 1.6m +237.3k +237,313 17.9%
10 CABALETTA BIO INC COM CABA CABA 1,973,253 $30.0m3.16% 3.16% AddedShares held: Q4 2022 1.9m, Q1 2023 2.0m, Q2 2023 2.0m, Q3 2023 2.0m +2 +2 0.0%
11 KALVISTA PHARMACEUTICALS INC COM KALV KALV 2,916,667 $28.1m2.96% 2.96% UnchangedShares held: Q4 2022 2.9m, Q1 2023 2.9m, Q2 2023 2.9m, Q3 2023 2.9m
12 GH RESEARCH PLC ORDINARY SHARES GHRS GHRS 2,744,125 $27.6m2.90% 2.90% ReducedShares held: Q4 2022 3.5m, Q1 2023 3.5m, Q2 2023 3.5m, Q3 2023 2.7m -773.0k -773,000 -22.0%
13 HILLEVAX INC COM COM 2,037,313 $27.4m2.88% 2.88% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 2.0m
14 SAVARA INC COM SVRA SVRA 7,184,865 $27.2m2.86% 2.86% AddedShares held: Q4 2022 6.4m, Q1 2023 6.4m, Q2 2023 6.4m, Q3 2023 7.2m +833.3k +833,334 13.1%
15 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 1,090,000 $25.0m2.63% 2.63% UnchangedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 1.1m, Q3 2023 1.1m
16 AMBRX BIOPHARMA INC SPONSORED ADS SPONSORED ADS 2,070,000 $23.8m2.51% 2.51% ReducedShares held: Q4 2022 0, Q1 2023 3.3m, Q2 2023 2.5m, Q3 2023 2.1m -415.0k -414,960 -16.7%
17 TRAVERE THERAPEUTICS INC COM TVTX TVTX 2,623,677 $23.5m2.47% 2.47% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 2.6m
18 DYNE THERAPEUTICS INC COM DYN DYN 2,173,913 $19.5m2.05% 2.05% UnchangedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 2.2m, Q3 2023 2.2m
19 CELCUITY INC COM CELC CELC 2,105,386 $19.2m2.03% 2.03% UnchangedShares held: Q4 2022 2.1m, Q1 2023 2.1m, Q2 2023 2.1m, Q3 2023 2.1m
20 TERNS PHARMACEUTICALS INC COM COM 3,092,273 $15.6m1.64% 1.64% AddedShares held: Q4 2022 3.7m, Q1 2023 3.6m, Q2 2023 3.0m, Q3 2023 3.1m +119.4k +119,404 4.0%
21 MERSANA THERAPEUTICS INC COM COM 11,328,000 $14.4m1.51% 1.51% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 11.3m
22 APPLIED THERAPEUTICS INC COM APLT APLT 5,658,034 $14.1m1.48% 1.48% UnchangedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 5.7m, Q3 2023 5.7m
23 ORIC PHARMACEUTICALS INC COM ORIC ORIC 2,142,856 $13.0m1.36% 1.36% UnchangedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 2.1m, Q3 2023 2.1m
24 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 927,706 $12.7m1.33% 1.33% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 927.7k
25 ADVERUM BIOTECHNOLOGIES INC COM COM 6,573,300 $9.9m1.04% 1.04% AddedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 3.9m, Q3 2023 6.6m +2.7m +2,687,054 69.1%
26 PRAXIS PRECISION MEDICINES I COM COM 5,304,410 $9.1m0.95% 0.95% UnchangedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 5.3m, Q3 2023 5.3m
27 ACELYRIN INC COM COM 864,332 $8.8m0.93% 0.93% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 864.3k
28 TREVI THERAPEUTICS INC COM TRVI TRVI 3,422,397 $7.5m0.79% 0.79% UnchangedShares held: Q4 2022 3.1m, Q1 2023 3.1m, Q2 2023 3.4m, Q3 2023 3.4m
29 ACLARIS THERAPEUTICS INC COM ACRS ACRS 1,040,754 $7.1m0.75% 0.75% UnchangedShares held: Q4 2022 4.6m, Q1 2023 1.0m, Q2 2023 1.0m, Q3 2023 1.0m
30 MILESTONE PHARMACEUTICALS IN COM MIST MIST 2,208,812 $6.8m0.72% 0.72% UnchangedShares held: Q4 2022 2.2m, Q1 2023 2.2m, Q2 2023 2.2m, Q3 2023 2.2m
31 PLIANT THERAPEUTICS INC COM PLRX PLRX 288,949 $5.0m0.53% 0.53% UnchangedShares held: Q4 2022 1.1m, Q1 2023 1.4m, Q2 2023 288.9k, Q3 2023 288.9k
32 SAGIMET BIOSCIENCES INC COM SER A SGMT SGMT 515,000 $4.5m0.48% 0.48% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 515.0k
33 AEGLEA BIOTHERAPEUTICS INC COM AGLE AGLE 295,034 $3.6m0.38% 0.38% ReducedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 6.3m, Q3 2023 295.0k -6.0m -6,048,187 -95.3%
34 LYRA THERAPEUTICS INC COM LYRA LYRA 924,170 $3.6m0.38% 0.38% UnchangedShares held: Q4 2022 924.2k, Q1 2023 924.2k, Q2 2023 924.2k, Q3 2023 924.2k
35 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 77,042 $951.5k0.10% 0.10% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 77.0k
36 RALLYBIO CORP COM COM 268,532 $905.0k0.10% 0.10% UnchangedShares held: Q4 2022 268.5k, Q1 2023 268.5k, Q2 2023 268.5k, Q3 2023 268.5k
37 AFFIMED N V COM COM 1,428,571 $682.7k0.07% 0.07% UnchangedShares held: Q4 2022 1.4m, Q1 2023 1.4m, Q2 2023 1.4m, Q3 2023 1.4m

Sold out since Q2 2023

SecurityTickerShares held beforeValue then
THESEUS PHARMACEUTICALS INC 770,000 $7.2m770.0k shares
BLACK DIAMOND THERAPEUTICS I BDTX BDTX 353,629 $1.8m353.6k shares
AVALO THERAPEUTICS INC 1,250,000 $444.0k1.2m shares